Condition: Mild Traumatic Brain Injury · Sponsor: Foundation for Advancing Veterans' Health Research
A two site, 2-arm, Phase III randomized pragmatic clinical trial evaluating the effectiveness of quetiapine monotherapy in comparison to Treatment As Usual (TAU) medication management for symptoms experienced by veterans receiving rehabilitation therapy for mild traumatic brain injury (mTBI) and comorbid symptoms of posttraumatic stress disorder (PTSD).
This description comes directly from the study's public registry record.
Muhammad R Baig, MD · 210-617-5300 · muhammad.baig@va.gov
Lizette Aviles, BS · 361-277-5486 · lizette.aviles@va.gov
Always discuss trial participation with your own doctor first.
| New Mexico VA Healthcare System | Albuquerque, New Mexico, United States | Recruiting |
| South Texas Veterans Healthcare System | San Antonio, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06333990